nach oben

Erschienen in:

01.10.2015 | Original Article

Membranous nephropathy and cerebellar degeneration with anti-GAD antibodies in type 2 diabetes mellitus

verfasst von: Franco Folli, Giuseppe Daniele, Sherry Werner, Subash Kamath, Jose Velez Munera, Hanna Abboud, Paolo Fanti

Erschienen in: Acta Diabetologica | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Aims

To study the potential pathogenic significance of the coexistence of membranous nephropathy, cerebellar degeneration and anti-glutamic acid decarboxylase (GAD) autoantibodies in patients with diabetes.

Methods

We performed a direct immunocytochemistry on human kidney slides, electron microscopy on human kidney biopsy, direct immunofluorescence on human kidney biopsy. Baboon and rat kidney cell lines were fractionated and subjected to western blotting with antibodies to GAD.

Results

In this patient we demonstrate the presence of autoantibodies to GAD, which is highly enriched in podocytes plasma membrane and tubular cells of the kidney as well as sub-endothelial IgG and complement C3 deposits in the glomerular basement membrane (GBM).

Conclusions

We hypothesize the existence in this patient of a common autoimmune pathogenic mechanism with GAD as the autoantigenic determinant, underlying cerebellar degeneration and membranous nephropathy.

Solimena M, Folli F, Denis-Donini S et al (1988) Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med 318:1012–1020CrossRefPubMed

Solimena M, Folli F, Aparisi R et al (1990) Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 322:1555–1560CrossRefPubMed

Baekkeskov S, Aanstoot HJ, Christgau S et al (1990) Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151–156CrossRefPubMed

Folli F (1998) Stiff man syndrome, 40 years later. J Neurol Neurosurg Psychiatry 65:618PubMedCentralCrossRefPubMed

Bonifacio E, Krumsiek J, Winkler C et al (2014) A strategy to find gene combinations that identify children who progress rapidly to type 1 diabetes after islet autoantibody seroconversion. Acta Diabetol 51:403–411CrossRefPubMed

Chmiel R, Beyerlein A, Knopff A et al (2014) Early infant feeding and risk of developing islet autoimmunity and type 1 diabetes. Acta Diabetol. doi:10.1007/s00592-014-0628-5 PubMed

Mahadeb YP, Gruson D, Buysschaert M et al (2014) What are the characteristics of phenotypic type 2 diabetic with low-titer GAD65 antibodies? Acta Diabetol 51:103–111CrossRefPubMed

Fiorina P, Venturini M, Folli F et al (2005) Natural history of kidney graft survival, hypertrophy, and vascular function in end-stage renal disease type 1 diabetic kidney-transplanted patients: beneficial impact of pancreas and successful islet cotransplantation. Diabetes Care 28:1303–1310CrossRefPubMed

Folli F, Guzzi V, Perego L et al (2010) Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients’ skin which are normalized by kidney-pancreas transplantation. PLoS ONE 5:e9923. doi:10.1371/journal.pone.0009923 PubMedCentralCrossRefPubMed

10.

Couser WG, Nangaku M (2006) Cellular and molecular biology of membranous nephropathy. J Nephrol 19:699–705PubMed

11.

Kasinath BS, Mujais SK, Spargo BH et al (1983) Non diabetic renal disease in patients with diabetes mellitus. Am J Med 75:613–617CrossRefPubMed

12.

Mundel P, Shankland SJ (2002) Podocyte biology and response to injury. J Am Soc Nephrol 13:3005–3015CrossRefPubMed

13.

Rego Filho EA, Mello SF, Omuro AM et al (2003) Simultaneous onset of steroid-sensitive nephrotic syndrome and type 1 diabetes. J Pediatr (Rio J) 79:557–560CrossRef

14.

Dittrich K, Knerr I, Rascher W et al (2006) Transient insulin-dependent diabetes mellitus in children with steroid-dependent idiopathic nephrotic syndrome during tacrolimus treatment. Pediatr Nephrol 21:958–961CrossRefPubMed

15.

Folli G, Pollak VE, Reid RT et al (1958) Electron-microscopic studies of reversible glomerular lesions in the adult nephrotic syndrome. Ann Intern Med 49:775–795CrossRefPubMed

16.

Honnorat J, Saiz A, Giometto B et al (2001) Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol 58:225–230CrossRefPubMed

17.

Reetz A, Solimena M, Matteoli M et al (1991) GABA and pancreatic beta-cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion. EMBO J 10:1275–1284PubMedCentralPubMed

18.

Monroy A, Kamath S, Chavez AO et al (2009) Impaired regulation of the TNF-alpha converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans. Diabetologia 52:2169–2181PubMedCentralCrossRefPubMed

19.

Moersch FP, Woltman HW (1956) Progressive fluctuating muscular rigidity and spasm (“stiff-man” syndrome); report of a case and some observations in 13 other cases. Mayo Clin Proc 31:421–427

20.

Peltola J, Kulmala P, Isojarvi J et al (2000) Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 55:46–50CrossRefPubMed

21.

McKnight K, Jiang Y, Hart Y et al (2005) Serum antibodies in epilepsy and seizure associated disorders. Neurology 65:1730–1736CrossRefPubMed

22.

Giometto B, Nicolao P, Macucci M et al (1998) Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies. Lancet 352:457CrossRefPubMed

23.

Kwan P, Sills GJ, Kelly K et al (2000) Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study. Epilepsy Res 42:191–195CrossRefPubMed

24.

Barker R, Revesz T, Thom M et al (1998) Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry 65:633–640PubMedCentralCrossRefPubMed

25.

Dinkel K, Meinck HM, Jury KM et al (1998) Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann Neurol 44:194–201CrossRefPubMed

26.

Geis C, Weishaupt A, Grünewald B et al (2011) Human stiff-person syndrome IgG induces anxious behavior in rats. PLoS ONE 6:e16775. doi:10.1371/journal.pone.0016775 PubMedCentralCrossRefPubMed

27.

Daw K, Ujihara N, Aktinson M et al (1996) Glutamic acid decarboxylase autoantibodies in Stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition. J Immunol 156:818–825PubMed

28.

Folli G, Onida L (1959) Biopsy and electron microscopy of the kidney. Sci Med Ital 8:19–58PubMed

29.

vanDamme BJC, Fleuren GJ, Bakker WW et al (1978) Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens: part IV: fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis. Lab Invest 38:502–510

30.

Kerjaschski D, Farquhar MG (1983) Immunochemical localization of the Heymann nephritis antigen (gp330) in glomerular epithelial cells of normal Lewis rats. J Exp Med 157:667–686CrossRef

31.

Neale TJ, Wilson CB (1982) Glomerular antigens in Heymann’s nephritis: reactivity of eluted and circulating antibody. J Immunol 128:323–330PubMed

32.

Madaio MP, Salant DJ, Cohen AJ et al (1983) Comparative study of in situ immune deposit formation in active and passive Heymann nephritis. Kidney Int 23:498–505CrossRefPubMed

33.

Couser WG, Salant DJ (1980) In situ immune complex formation and glomerular injury. Kidney Int 17:1–13CrossRefPubMed

34.

Beck LH Jr, Bonegio RG, Lambeau G et al (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361:11–21PubMedCentralCrossRefPubMed

35.

Qin W, Beck LH Jr, Zeng C et al (2011) Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 22:1137–1143PubMedCentralCrossRefPubMed

36.

Hoxha E, Harendza S, Zahner G et al (2011) An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 26:2526–2532CrossRefPubMed

37.

Debiec H, Ronco P (2011) PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med 364:689–690CrossRefPubMed

38.

Prunotto M, Carnevali ML, Candiano G et al (2010) Autoimmunity in membranous nephropathy targets aldose reductase and SOD2. J Am Soc Nephrol 21:507–519PubMedCentralCrossRefPubMed

39.

Bruschi M, Carnevali ML, Murtas C et al (2011) Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: alfa-enolase and borderline antigens. J Proteomics 74:2008–2017CrossRefPubMed

Titel: Membranous nephropathy and cerebellar degeneration with anti-GAD antibodies in type 2 diabetes mellitus
verfasst von: Franco Folli
Giuseppe Daniele
Sherry Werner
Subash Kamath
Jose Velez Munera
Hanna Abboud
Paolo Fanti
Publikationsdatum: 01.10.2015
Verlag: Springer Milan
Erschienen in: Acta Diabetologica / Ausgabe 5/2015
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-015-0728-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2015

Platelet-derived miR-103b as a novel biomarker for the early diagnosis of type 2 diabetes

Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site

High-sensitivity C-reactive protein, but not white blood cell count, independently predicted incident diabetes in a Japanese health screening population

Strong evidence of sexual dimorphic effect of adiposity excess on insulin sensitivity

Impact of intensive treatment on serum methylglyoxal levels among individuals with screen-detected type 2 diabetes: the ADDITION-Denmark study